PATENT CLAIM ANALYSIS

Application Number: 16131754
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["514", "013300"]

Abstract:
Mimetic peptides having anti-angiogenic and anti-tumorigenic properties and methods of their use for treating cancer, ocular diseases, such as age-related macular degeneration, and other-angiogenesis-dependent diseases are disclosed. More particularly, active non-cysteine analogs (mimetics), which exhibit anti-angiogenic activity in endothelial cell proliferation, migration, adhesion, and tube formation assays, anti-migratory activity in human breast cancer cells in vitro, anti-angiogenic and anti-tumori-genic activity in vivo in breast cancer xenograft models, and age-related macular degeneration models are disclosed. The presently disclosed mimetic peptides also exhibit anti-lymphangiogenic and directly anti-tumorigenic properties.

Claim (Index 12):
The method of  claim 11 , wherein X is a natural amino acid.

Metadata:
- Claim Count in Document: 65.0
- Percentile: 97.0
- Lexical Diversity: 1.67213
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15395648', '13992998', '14896521', '13920103', '10984270']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8032858342023356
- 35 USC 102 Novelty (BERT): 0.5969161816140987
- Combined Prediction Score: 0.7826488689435119
- Mean Citation Score: 454.475882
- Max Citation Score: 594.0758
- Similarity Product: 402.97473043112745

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test